يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Bakker, S D"', وقت الاستعلام: 1.54s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    مورد إلكتروني

    المصدر: de Boo, L W; Jóźwiak, K; Ter Hoeve, N D; van Diest, P J; Opdam, M; Wang, Y; Schmidt, M K; de Jong, V; Kleiterp, S; Cornelissen, S; Baars, D; Koornstra, R H T; Kerver, E D; van Dalen, T; Bins, A D; Beeker, A; van den Heiligenberg, S M; de Jong, P C; Bakker, S D; Rietbroek, R C; Konings, I R; Blankenburgh, R; Bijlsma, R M; Imholz, A L T; Stathonikos, N; Vreuls, W; Sanders, J; Rosenberg, E H; Koop, E A; Varga, Z; et al (2024). Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer. ESMO Open, 9(3):102923.

  4. 4
  5. 5
    مورد إلكتروني

    المصدر: de Boo , L W , Jóźwiak , K , Ter Hoeve , N D , van Diest , P J , Opdam , M , Wang , Y , Schmidt , M K , de Jong , V , Kleiterp , S , Cornelissen , S , Baars , D , Koornstra , R H T , Kerver , E D , van Dalen , T , Bins , A D , Beeker , A , van den Heiligenberg , S M , de Jong , P C , Bakker , S D , Rietbroek , R C , Konings , I R , Blankenburgh , R , Bijlsma , R M , Imholz , A L T , Stathonikos , N , Vreuls , W , Sanders , J , Rosenberg , E H , Koop , E A , Varga , Z , van Deurzen , C H M , Mooyaart , A L , Córdoba , A , Groen , E , Bart , J , Willems , S M , Zolota , V , Wesseling , J , Sapino , A , Chmielik , E , Ryska , A , Broeks , A , Voogd , A C , van der Wall , E , Siesling , S , Salgado , R , Dackus , G M H E , Hauptmann , M , Kok , M & Linn , S C 2024 , ' Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer ' , ESMO Open , vol. 9 , no. 3 , 102923 .

  6. 6
    دورية أكاديمية
  7. 7
  8. 8
  9. 9
    مورد إلكتروني

    المصدر: de Joode , K , Tol , J , the DOCC investigators , Hamberg , P , Cloos , M , Kastelijn , E A , Borgers , J S W , Nuij , V J A A , Klaver , Y , Herder , G J M , Mutsaers , P G N J , Dumoulin , D W , Oomen-de Hoop , E , van Diemen , N G J , Libourel , E J , Geraedts , E J , Bootsma , G P , van der Leest , C H , Peerdeman , A L , Herbschleb , K H , Visser , O J , Bloemendal , H J , van Laarhoven , H W M , de Vries , E G E , Hendriks , L E L , Beerepoot , L V , Westgeest , H M , van den Berkmortel , F W P J , Dingemans , A M C , van der Veldt , A A M , van Leeuwen , L , van der Meer , F S , Tiemessen , M A , van Diepen , D M , Brocken , P , Drooger , J C , de Groot , J W B , Stigt , J A , Slingerland , M , Haberkorn , B C M , Aarts , M J B , Youssef , M , Faber , L M , van de Wetering , R A W , Bard , M P L , Douma , G , Suijkerbuijk , K P M , Bakker , S D , de Jong , W K , Staal , A J & Franken , B 2022 , ' Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19 : an update from the Dutch Oncology COVID-19 Consortium ' , European Journal of Cancer , vol. 160 , pp. 261-272 .

  10. 10